LSB

LakeShore Biopharma
LSB

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

LSB was delisted on the 19th of September, 2025.

Back to rankings

9 hedge funds and large institutions have $3.79M invested in LakeShore Biopharma in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$275K

Top Sellers

1
-$1.23M
2
-$821K
3
-$698K
4
Citadel Advisors
Citadel Advisors
Florida
-$23.1K
5
TRCT
Tower Research Capital (TRC)
New York
-$2
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.1M
2
$843K
3
$816K
4
$526K
5
$275K
6
$216K
7
$9.53K
8
$3.58K
9
$359
10
–
11
–
12
–